Squarepoint’s Danimer Scientific, Inc. DNMR Stock Holding History

Squarepoint’s Portfolio DNMR Stock Details DNMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-250	Closed	-$378K	–	3800
2021 Q1	$378K	Buy	+250	New	+$406K	﹤0.01%	2240

Other funds holding DNMR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Teramo Advisors Naples, Florida $529M AUM 20.59% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

Squarepoint's DNMR Position: Q1 2023 in Review

Squarepoint sold out of Danimer Scientific, Inc. (DNMR) in Q1 2023, closing a stake of 317 shares — an estimated $22.7K sold.

Squarepoint first reported a position in DNMR in Q1 2021 and held it in 6 quarters. The position peaked at $1.52M in Q4 2021. 160 funds tracked by Wall St. Rank hold DNMR as of Q1 2023.

Squarepoint reported no remaining Danimer Scientific, Inc. position as of Q1 2023 after selling out during the quarter.
Squarepoint sold 317 Danimer Scientific, Inc. shares in Q1 2023, an estimated $22.7K.
Squarepoint first reported a position in Danimer Scientific, Inc. in Q1 2021 and held it in 6 quarters.
Squarepoint's Danimer Scientific, Inc. position peaked at $1.52M in Q4 2021.
160 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q1 2023.

Based on Squarepoint's 13F filing for Q1 2023, filed 15 May 2023.